Praxis der Surfactanttherapie

• Literatur

• 1 Fujiwara T, Chida S, Watabe Y et al. Artificial surfactant therapy in hyaline-membrane disease. The Lancet 1980; 315: 55-59
• 2 Avery ME, Mead J. Surface properties in relation to atelectasis and hyaline membrane. AM J Dis Child 1959; 5: 517-523
• 3 Robillard E, Alarie Y, Dagenais-Perusse P et al. Microaerosol administration of synthetic beta-gamma-dipalmitolyl-l-alpha-lecitin in the respiratory distress syndrome: a preliminary report. Can Med Assoc J 1964; 90: 55-57
• 4 Halliday HL. Surfactants: past, present and future. J Perinatol 2008; 28: 47-56
• 5 Ramanathan R. Choosing a right surfactant for Respiratory Distress Syndrome treatment. Neonatology 2009; 95: 1-5
• 6 Soll RF, Blanco F. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome. Chochrane Database Syst Rev 2001; DC000144
• 7 Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006; CD004454
• 8 Herting E, Schiffmann H, Roth C et al. Surfactant lavage demonstrates protein fibrils in an neonate with congenital surfactant protein b deficiency. Am JRespir Crit Care Med 2002; 166: 1292-1294
• 9 Valls-i-Soler A, López-Herida J, Fernández-Ruanova MB et al. A simplified surfactant dosing procedure in respiratory distress syndrome: the “side-hole” randomized study. Spanish Surfactant Collaborative Group. Acta Paediatr 1997; 86: 747-751
• 10 Stevens TP, Harrington EW, Blennow M et al. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilaton for preterm infants with or at risk for respiratoiry distress syndrome. Cochrane Syst Rev 2007; CD003063
• 11 Verder H, Robertson B, Greisen G et al. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. N Engl J Med 1994; 331: 1051-1055
• 12 Bohlin K, Jonsson B, Gustafsson A-S et al. Continuous positive airway pressure and surfactant. Neonatology 2008; 93: 309-315
• 13 Kribs A, Pillekamp F, Hünseler C et al. Early administration of surfactant in spontaneous breathing with nCPAP: feasibility and outcome in extremely premature infants (postmenstrual age ≤ 27 weeks). Paediatr Anaesth 2007; 17: 364-369
• 14 Kribs A, Härtel C, Kattner E et al. Spontaneous breathing in preterm infants with respiratory distress: first multi-center data. Klin Paediatr 2010; 222: 13-17
• 15 Goepel W, Kribs A, Ziegler A et al. Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial. Lancet 2011; 378: 1627-1634
• 16 Herting E, Kribs A, Roth B et al. Intratracheal surfactant instillation using a thin diameter tube in spontaneously breathing infants – on the way to clinical practice in Germany?. Neonatology 2012; 101: 362 (Abstract)
• 17 Kribs A, Roll C, Göpel W et al. Eine endotracheale Surfactantgabe unter CPAP-unterstützter Spontanatmung optimiert das Outcome extrem unreifer Frühgeborener – Ergebnisse der NINSAPP-Studie (Non Intubated Surfactant Application). Monatsschr Kinderheilkd 2013; 161: 1, 23 (Abstract)
• 18 Dargaville PA. Innovation in surfactant therapy I: surfactant lavage and surfactant administration by fluid bolus using minimal invasive techniques. Neonatology 2012; 101: 326-336
• 19 Klebermass-Schrehof K, Wald M, Schwindt J et al. Less Invasive Surfactant Administration in Extremely Preterm Infants: Impact on Mortality and Morbidity. Neonatology 2013; 103: 252-258
• 20 Herting E, Kribs A, Roth B et al. Growth and development of VLBW-infants after less invasive surfactant administration during spontaneous breathing: two year follow-up of the AMV-trial. Neonatology 2013; 103: 349 (Abstract)
• 21 Kanmaz HG, Erdeve O, Canpolat FE et al. Surfactant Administration via Thin Catheter During Spontaneous Breathing: Randomized Controlled Trial. Pediatrics 2013; 131: e502-e509
• 22 Dargaville PA, Aiyappan A, De Paoli AG et al. Minimally-invasive surfactant therapy in preterm infants on continuous positive airway pressure. Arch Dis Child Fetal Neonatal 2013; 98: F122-126
• 23 Support Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network. Early CPAP versus surfactant in extremely preterm infants. N Engl J Med 2010; 362: 1970-1979
• 24 Morley CJ, Davis PG, Doyle LW et al. COIN Trial Investigators. Nasal CPAP or intubation at birth for very preterm infants. N Engl J Med 2008; 358: 700-708
• 25 Pillow JJ, Minocchieri S. Innovation in surfactant therapy II: surfactant administration by aerosolization. Neonatology 2012; 101: 337-344
• 26 Kattwinkel J, Robinson M, Bloom BT et al. Technique for intrapartum administration of surfactant without requirement for an endotracheal tube. J Perinatol 2004; 24: 360-365
• 27 Sweet DG, Carnielli V, Greisen G et al. European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants – 2013 update. Neonatology 2013; 103: 353-368
• 28 Rojas-Reyes MX, Morley CJ, Soll R. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2012; CD000510
• 29 Gortner L, Herting E. Sufactanttherapie des Atemnotsyndroms Frühgeborener (RDS). AWMF-Leitlininien-Register 024/021
• 30 Ramanathan R, Rasmussen MR, Gerstmann DR et al. A randomized multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants. Am J Perinatol 2004; 21: 109-119
• 31 Speer CP, Robertson B, Curstedt T et al. Randomized European multicenter trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome: single versus multiple doses of Curosurf. Pediatrics 1992; 89: 13-20
• 32 Findlay RD, Taeusch HW, Walther FJ. Surfactant replacement therapy for meconium aspiration syndrome. Pediatrics 1996; 97: 48-52
• 33 Herting E, Gefeller O, Land M et al. Surfactant treatment of neonates with respiratory failure and group B streptococcal infection. Pediatrics 2000; 106: 957-964
• 34 Pandit PB, Dunn MS, Kelly EN et al. Surfactant replacement in neonates with early chronic lung disease. Pediatrics 1995; 95: 851-854
• 35 Aziz A, Ohlsson A. Surfactant for pulmonary haemorrhage in neonates. Cochrane Database Syst Rev 2012; CD005254
• 36 Wiswell TE, Knight GR, Finer NN et al. A multicenter, randomized, controlled trial comparing Surfaxin (Lucinactant) lavage with standard care for treatment of meconium aspiration syndrome. Pediatrics 2002; 109: 1081-1087
• 37 Herting E, Gan X, Rauprich P et al. Combined treatment with surfactant and specific immunoglobulin reduces bacterial proliferation in experimental neonatal group B streptococcal pneumonia. Am J Respir Crit Care Med 1999; 159: 1862-1867